0001209191-17-006701.txt : 20170201
0001209191-17-006701.hdr.sgml : 20170201
20170201162348
ACCESSION NUMBER: 0001209191-17-006701
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170126
FILED AS OF DATE: 20170201
DATE AS OF CHANGE: 20170201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Conatus Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001383701
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203183915
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16745 WEST BERNARDO DRIVE
STREET 2: Suite 200
CITY: San Diego
STATE: CA
ZIP: 92127
BUSINESS PHONE: (858) 376-2600
MAIL ADDRESS:
STREET 1: 16745 WEST BERNARDO DRIVE
STREET 2: Suite 200
CITY: San Diego
STATE: CA
ZIP: 92127
FORMER COMPANY:
FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc
DATE OF NAME CHANGE: 20061214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Edward F III
CENTRAL INDEX KEY: 0001670699
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36003
FILM NUMBER: 17565202
MAIL ADDRESS:
STREET 1: C/O CONATUS PHARMACEUTICALS INC.
STREET 2: 16745 WEST BERNARDO DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-26
0
0001383701
Conatus Pharmaceuticals Inc.
CNAT
0001670699
Smith Edward F III
C/O CONATUS PHARMACEUTICALS INC.
16745 WEST BERNARDO DRIVE, SUITE 200
SAN DIEGO
CA
92127
0
1
0
0
SVP, Reg Affairs and QA
Stock Option (Right to Buy)
4.21
2017-01-26
4
A
0
57500
0.00
A
2027-01-25
Common Stock
57500
57500
D
The option was granted on January 26, 2017. 25% of the total number of shares of common stock subject to the option will vest on January 26, 2018, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/ Charles J. Cashion, Attorney-in-Fact for Edward F. Smith, III
2017-02-01